1.0
29 Dec 2022
Anonymous employee
Former employee, less than 1 year
Recommend
CEO approval
Business outlook
Pros
Really good benefits and compensation. Good coworkers. A product that can really benefit the T1D community
Cons
Horribly managed across the board...the worst in my career. They went on a hiring spree in 2022, preparing for commercial launch, only to let almost half the company (80 to 90 human beings) go in late August. I believe they have no intention of bringing their pump to market under BB. They brought in a new CEO and CFO with the intent, in my opinion, to sell the IP once FDA approved (check their history).